Severaal structurally different hypolipidemic compounds and certain phthalate ester plasticizers, the two classes of peroxisome proliferators (PPs) induce, altered areas, neoplastic nodules, and hepatocellular carcinomas in rats and mice after chronic dietary administrtaion. The phenotypic properties of hepatic lesions induced by PPs are signifcantly different from those induced by classical carcinogens. Based on these differences we hypothesize a possible divergence in the mechanism of action by which nomutagenic PPs and classical carcinogens induce liver tumors. We propose that these differences are probably due to a field effect of highly electrophilic reactans of classical carcinogens affecting a variety of genes, whereas the PPs, which probably act by a receptor mediated mechanism, alter the expression of a highly selected set of genes.
The specific aims are: 1) Comparative evaluation of the biologic properties of hepatic lesions in the rat induced by 2 structurally different hypolipidemic peroxisome proliferators, Wy-14,643 and ciprofibrate with those induced by a classical carcinogen by evaluation of: a) phentypic properties, b) functional properties of AA, NN and HCC, and c) autonomous growth properties of AA and NN in the host livers after discontinuation of PP treatment and after transplantaton into syngeneic rats. 2) Examination of NN and HCC induced by PPs, Wy-14,643 and ciprofibrate, and those induced by a classical carcinogen for the expression of genes coding for albumin, alpha- feto-protein, catalase, enzymes of peroxsomal beta-oxidation system, selected phase II drug detoxifying enzymes, DT- diaphorase and epoxide hydrolase by a) measuring mRNA levels using specific cDNA probes, b) examining methylation pattern of AFP, albumin and beta-oxidation enzymes genes using methylation sensitive restriction enzymes, and c) evaluating the amplification of beta-exidation enzyme genes. 3) Examination of Nn and HCC induced by classical genotoxic carcinogens and PPs for differences in the expression of oncogenes compared to one another and to the surrounding normal liver using northern blot analysis and by in situ hybridiation. 4) Identification of oncogene(s) in DNA of HCC induced by PPs using NIH 3T3 cell transformation assay and determination of the mechanism by which they have been activated. 5) Further characterization of HCC of different degree of differentiation and examine for morphological functional properties after a) developing of transplantable tumors, and b) establishing cell lines.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Chemical Pathology Study Section (CPA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northwestern University at Chicago
School of Medicine & Dentistry
United States
Zip Code
Rao, M S; Thangada, S; Subbarao, V (1991) Peroxisome proliferation in neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. Exp Pathol 41:44-9
Bartles, J R; Khuon, S; Lin, X H et al. (1990) Peroxisome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins. Cancer Res 50:669-76
Rao, M S; Yeldandi, A V; Subbarao, V (1990) Quantitative analysis of hepatocellular lesions induced by di(2-ethylhexyl)phthalate in F-344 rats. J Toxicol Environ Health 30:85-9
Rao, M S; Reddy, J K (1989) The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis. Drug Metab Rev 21:103-10
Yeldandi, A V; Milano, M; Subbarao, V et al. (1989) Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett 47:21-7
Nemali, M R; Reddy, M K; Usuda, N et al. (1989) Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol Appl Pharmacol 97:72-87
Kasai, H; Okada, Y; Nishimura, S et al. (1989) Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 49:2603-5
Nemali, M R; Usuda, N; Reddy, M K et al. (1988) Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 48:5316-24
Rao, M S; Nemali, M R; Usuda, N et al. (1988) Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res 48:4919-25
Rao, M S; Dwivedi, R S; Subbarao, V et al. (1988) Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound. Br J Cancer 58:46-51

Showing the most recent 10 out of 21 publications